Caliper Eyes Expansion into Companion Dx with New Platforms | GenomeWeb

By Edward Winnick

SAN FRANCISCO (GenomeWeb News) – Caliper Life Sciences hopes to receive the CE IVD Mark this year for its new LabChip Dx instrument as it looks to potential partnerships to help build content for the new platform, President and CEO Kevin Hrusovsky told GenomeWeb Daily News.

Speaking in advance of Caliper's presentation Thursday at the JP Morgan Healthcare Conference here, he also said his firm believes it has the tools pharma firms will want in developing companion diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.